Progenitor cells maintain self-renewing tissues throughout life by sustaining their capacity for proliferation while suppressing cell cycle exit and terminal differentiation 1, 2 . DNA methylation [3] [4] [5] provides a potential epigenetic mechanism for the cellular memory needed to preserve the somatic progenitor state through repeated cell divisions. DNA methyltransferase 1 (DNMT1) 6, 7 maintains DNA methylation patterns after cellular replication. Although dispensable for embryonic stem cell maintenance 8 , the role for DNMT1 in maintaining the progenitor state in constantly replenished somatic tissues, such as mammalian epidermis, is unclear. Here we show that DNMT1 is essential for epidermal progenitor cell function. DNMT1 protein was found enriched in undifferentiated cells, where it was required to retain proliferative stamina and suppress differentiation. In tissue, DNMT1 depletion led to exit from the progenitor cell compartment, premature differentiation and eventual tissue loss. Genome-wide analysis showed that a significant portion of epidermal differentiation gene promoters were methylated in selfrenewing conditions but were subsequently demethylated during differentiation. Furthermore, UHRF1 (refs 9, 10), a component of the DNA methylation machinery that targets DNMT1 to hemimethylated DNA, is also necessary to suppress premature differentiation and sustain proliferation. In contrast, Gadd45A 11, 12 and B 13 , which promote active DNA demethylation, are required for full epidermal differentiation gene induction. These data demonstrate that proteins involved in the dynamic regulation of DNA methylation patterns are required for progenitor maintenance and selfrenewal in mammalian somatic tissue.
In self-renewing mammalian epithelial tissues, which are the sites of most human malignancies 14 , the basis for repressed differentiation in somatic stem cells is unclear. Epigenetic gene silencers, such as DNMT1 (ref. 4) , may help preserve progenitor gene expression patterns through repeated cell divisions. Loss of function studies have demonstrated the importance of DNMT1 for imprinting, embryogenesis and tumorigenesis 15 . DNMT1 knockout mice display delayed development and lethality by mid-gestation, hindering analysis of the function of DNMT1 in self-renewing epithelia, such as epidermis 7, 16 . In epidermis, undifferentiated progenitor cells residing in the basement membranebound basal layer undergo cell cycle arrest, outward migration and terminal differentiation to generate the cutaneous permeability barrier. Consistent with a role in this process, DNMT1 transcript and protein were repressed on calcium-induced differentiation of human keratinocytes in culture ( Fig. 1a-c, Supplementary Table 1 ). DNMT1 protein was mainly confined to cells of the basal layer of adult human epidermal tissue and was absent in outer differentiated layers ( Fig. 1d ). Thus, DNMT1 is expressed in epidermal progenitor-containing cell populations and is lost during differentiation.
To study effects of DNMT1 loss on epidermal progenitor function in vivo, short hairpin RNA constructs targeting DNMT1 (DNMT1i) were generated ( Supplementary Fig. 1 ). DNMT1i and control knockdown cells were used to regenerate human skin on immune-deficient mice by an approach recapitulating features of intact tissue, including epidermal self-renewal kinetics 17, 18 . By 2 weeks, DNMT1i epidermis was markedly hypoplastic ( Fig. 2a ) without increased cell death ( Supplementary Fig. 2 ), and only 34% of DNMT1-deficient epidermal tissues survived to week 3 compared to 100% for controls ( Fig. 2a, b ). DNMT1i tissue displayed ectopic expression of differentiation genes, such as keratin 1 (K1, also known as KRT1), in the normally undifferentiated basal layer ( Fig. 2a ), indicating that premature differentiation occurs in the absence of DNMT1. Granular layer proteins were not seen in the basal layer of DNMT1i epidermis, possibly because of DNMT1i cell loss from this setting before their expression (data not shown). Consistent with premature entry into the post-mitotic differentiation pathway, DNMT1 depletion also diminished cell proliferation by week 3 to ,15% of control ( Supplementary  Fig. 3a, b ). These results indicate that epidermal DNMT1 loss leads to premature differentiation within the progenitor-containing compartment and loss of tissue self-renewal.
To confirm that the inability of DNMT1-deficient tissue to persist was due to a cell-intrinsic loss of progenitor function as opposed to a global tissue failure process, an in vivo epidermal progenitor cell competition assay was developed using tissue mosaicism ( Fig. 2c ). Epidermal cells marked with a construct expressing a haemagglutinin (HA) tag were infected with DNMT1i or control vectors and mixed with unmarked cells. These cells were then used to regenerate mosaic human epidermis in vivo. Initially, there were a similar percentage of DNMT1i and control cells contributing to all layers ( Fig. 2d, e ). By week 2, however, there was a significant decrease in the number of DNMT1i cells in the basal layer, with up to 11% of retained cells displaying ectopic expression of differentiation genes ( Supplementary Fig. 4 and Fig. 2d, e ). In contrast, marked cells in control shRNA epidermis remained stable without signs of ectopic differentiation (Fig. 2d , e and Supplementary Fig. 4 ). By week 3, DNMT1i cells generated with several DNMT1 shRNA constructs comprised ,2% of the basal layer compared to .30% for controls, a process paralleled by progressive loss of DNMT1i cells from suprabasal layers ( Fig. 2e ). Thus, DNMT1 loss leads to a cell-intrinsic failure of epidermal progenitor maintenance and premature differentiation.
Next, global gene expression profiles in DNMT1-deficient cells cultured in growth conditions was compared to that of control cells induced to differentiate with calcium. 3,343 genes (1,366 induced; 1,977 repressed) changed during calcium-induced differentiation and 797 genes (450 induced; 347 repressed) were altered by DNMT1 loss (Supplementary Tables 1 and 2 ). Comparing these two gene sets showed a statistically significant overlap of 545 genes, the vast majority of which were regulated in the same direction (Fig. 3a, b and Supplementary  Table 3 ). Upregulated genes in this shared set were enriched for differentiation gene ontology terms, whereas repressed genes were enriched for proliferation gene ontology terms ( Fig. 3a ). DNMT1 thus controls an epidermal gene expression program compatible with a role in sustaining proliferation and repressing differentiation.
To study the basis for the impaired proliferation seen with DNMT1 loss, we examined the proliferative stamina of epidermal progenitors. DNMT1i cells prematurely exited S phase into G1 arrest, similar to cells undergoing calcium-induced differentiation ( Fig. 3c, d ). In clonogenic assays, single DNMT1i cells failed to proliferate into larger colonies (.5 mm 2 ), producing only small, abortive colonies ( Fig. 3e , f). Similar to in vivo, decreased cell numbers were not due to increased apoptosis ( Supplementary Fig. 5 ). Rather, DNMT1 loss resulted in the upregulation of cyclin-dependent kinase (Cdk) inhibitors, p15 INK4B and p16 INK4A ( Fig. 3b and Supplementary Table 2 ), implicated in inhibiting stem cell self-renewal [19] [20] [21] . In keratinocytes, the effects of p15 INK4B and p16 INK4A can be bypassed by co-expression of Cdk4 and cyclin D1 (ref. 22 ). This G1 Cdk-cyclin pair partially rescued DNMT1i cell proliferation ( Supplementary Fig. 6a, b ). Wild-type DNMT1, but not a catalytically inactive point mutant 23 , reversed the proliferation defects as well as the Cdk inhibitor induction observed with DNMT1 loss ( Supplementary Fig. 7 ), indicating that DNMT1 DNA methylation capacity is required to repress p15 INK4B /p16 INK4A to permit progenitor proliferation. These data indicate that DNMT1 sustains progenitor proliferation by inhibiting expression of Cdk inhibitors. The DNMT1 requirement in maintaining the progenitor state indicates that DNA methylation changes during differentiation. Methylated DNA immunoprecipitations (MeDIP) 24, 25 were thus performed in undifferentiated and differentiated keratinocytes followed by hybridization to promoter tiling arrays covering 24,659 human genes ( Supplementary Tables 4 and 5 ). Methylated DNA enrichment was found on 5,999 gene promoters in undifferentiated keratinocytes ( Supplementary Table 4 ), with an overabundance of differentiation genes ( Fig. 4a ). Of the 1,366 induced differentiation genes, 364 had methylated DNA promoters in undifferentiated cells ( Fig. 4b and Supplementary Table 6 ), .50% of which lost methylation during differentiation ( Fig. 4b and Supplementary Table 7 ). Of the 232 differentially methylated genes, 75% contained a CpG island within 2 kilobases (kb) upstream of their transcription start site (Supplementary Table 7 ), a proportion similar to that in the epidermal differentiation gene set above as well as in the human genome. Among the 232 genes, a significant portion exhibited methylation in undifferentiated cells in regions outside of CpG islands known as 'shores' ( Supplementary Fig. 8 ), which exhibit tissue-specific methylation patterns correlated with gene expression 26 . These methylation marks were erased from these low CpG shores during epidermal differentiation. Because of variability in distance of shores from CpG islands, some of which are .2 kb away 26 , the shores for all genes were not encompassed within the tiled region of the arrays. Thus, the genes regulated in this manner during epidermal differentiation may be underestimated. MeDIP-coupled QPCR confirmed that differentiation genes, such as LCE3D and S100P, lost DNA methyl marks more than threefold during differentiation, whereas the stably imprinted gene, KCNQ1, remained unaltered ( Fig. 4c ). Bisulphite sequencing of S100P corroborated MeDIP profiling (Supplementary Fig. 9 ). Several transcription factors regulating epidermal differentiation [27] [28] [29] [30] , including POU2F3, MAFF and SP1 ( Fig. 4c and Supplementary Table 7 ) also lost methylation during differentiation, corresponding with increased expression ( Supplementary Table 1 ). Interestingly, 372 of the 1,977 genes repressed during differentiation became de novo methylated during differentiation, possibly via the de novo DNMTs, 3A and 3B, which are both expressed in keratinocytes (Supplementary Table 8 ). DNA methylation thus undergoes dynamic alterations during epidermal differentiation.
The SET and RING finger-associated (SRA) domain of UHRF1 (refs 9, 10) binds DNMT1 and recruits it to hemi-methylated DNA. Similar to DNMT1, UHRF1 was predominately detected in the epidermal basal layer and was downregulated during differentiation ( Supplementary Fig. 10a-c ). UHRF1 depletion ( Supplementary  Fig. 10d ) derepressed differentiation genes in progenitors (Supplementary Fig. 10e ) and markedly reduced their proliferative potential ( Supplementary Fig. 10f, g) . DNMT1-UHRF1 preservation of progenitor function predicted that mediators of DNA demethylation might induce epidermal differentiation. In support of this, Gadd45A 11,12 and B 13 , which interact with components of both base excision (BER) and nucleotide excision repair (NER) DNA demethylase complexes to demethylate DNA, were induced during epidermal differentiation ( Fig. 4d and Supplementary Table 1 ). Gadd45 depletion inhibited calcium induction of genes shown to be demethylated during differentiation and impaired erasure of S100P promoter DNA methylation ( Fig. 4e and Supplementary Fig. 9 , Supplementary Table  7 ). Furthermore, increasing Gadd45 expression induced premature differentiation and inhibited progenitor growth ( Fig. 4f-h ). DNMT1 and Gadd45 impacts in epidermal progenitors indicate they may function similarly in other tissues. Consistent with this, DNMT1 expression is downregulated during muscle differentiation (Supplementary Fig. 11a ) and DNMT1 depletion or enforced Gadd45 expression results in the increased expression of skeletal muscle differentiation genes such as skeletal actin, tropomyosin and myosin heavy chain ( Supplementary Fig. 11b-d) .
Taken together, these data indicate that tissue self-renewal may be controlled by a dynamic antagonism between regulators of DNA methylation. In this model, the progenitor state is sustained by methylation-induced silencing of the differentiation program via the concerted actions of DNMT1 and UHRF1; their retention in some lower suprabasal epidermal cells indicates their action may be partially retained early in differentiation. The differentiated cell fate, in contrast, LETTERS is promoted by Gadd45 DNA demethylation-enhancing proteins. The basis for the reciprocal expression of DNMT1-UHRF1 in progenitors and Gadd45 in differentiation, as well as whether this balance is disrupted in epithelial cancers, represents avenues for future study.
METHODS SUMMARY
Tissue culture. Primary human keratinocytes were derived from fresh foreskin. Cells were grown in KSF-M (GIBCO-BRL) supplemented with epidermal growth factor (EGF) and bovine pituitary extract (BPE). Cells were induced to differentiate by the addition of 1.2 mM calcium for 1 and 3 days in full confluence. Amphotropic phoenix cells were maintained in DMEM and 10% fetal bovine serum.
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METHODS
Tissue culture. Primary human keratinocytes were derived from fresh foreskin. Cells were grown in KSF-M (GIBCO-BRL) supplemented with epidermal growth factor (EGF) and bovine pituitary extract (BPE). Cells were induced to differentiate by the addition of 1.2 mM calcium for 1 and 3 days in full confluence. Amphotropic phoenix cells were maintained in DMEM and 10% fetal bovine serum. Primary human myoblasts were purchased from Cell Applications and maintained in muscle growth medium (Cell Applications, 151-500). Myoblasts were induced to differentiate in muscle differentiation medium (Cell Applications, 151D-250) for 24 or 72 h. Gene transfer. Amphotropic phoenix cells were transfected with 3 mg of each retroviral expression construct. Transfections were done in six-well plates using Lipofectamine 2000 (Invitrogen). Viral supernatants were collected 48 h post transfection and polybrene added (5 mg ml 21 ). These supernatants were placed on primary human keratinocytes and centrifuged for 1 h. Cells were transduced two times and selected using puromycin (1 mg ml 21 ) after the last transduction. GTATGAGTGGAAATTAAGA. The control shRNA used was a non-functional sequence targeting DNMT1. The control sequence is GCTTCAATTCGCGCA CCTA. Functional shRNA constructs targeting GADD45B were purchased from Open Biosystems with the following catalogue numbers: RHS4917-99748642 and RHS4917-99753120. Constructs for overexpressing GADD45A and GADD45B were made by cloning the GADD45A and GADD45B ORF into the LZRS retroviral vector. The cloning primers used for GADD45A and GADD45B were GADD45A for, ACGCAAAGCTTGCCACCATGACTTTGGAGGAATTC TCGGCTGGAGAGC; GADD45A rev, ACGCAGCGGCCGCTCACCGTTCAG GGAGATTAATCACTGGAACC; GADD45B for, ACGCAAAGCTTGCCACC ATGACGCTGGAAGAGCTCGTGGCGTGCGACA; GADD45B rev, ACGCAGC GGCCGCTCAGCGTTCCTGAAGAGAGATGTAGGGGA. The reporter construct HAK14 was cloned by fusing 33 haemagglutinin tag to keratin 14 and cloned into the LZRS retroviral vector. The wild-type DNMT1 construct was generated by purchasing the full length cDNA from Open Biosystems (MHS1768-98980929) and cloning into the LZRS retroviral vector. The catalytically inactive DNMT1 mutant construct was generated by using the Stratagene QuikChange mutagenesis kit using the following primers: 59 DNMT mut A, GCTGTGCGGCGGGCCG CCCAGCCAGGGCTTCAGCGGCATG and 39 DNMT mutA, CATGCCGCTG AAGCCCTGGCTGGGCGGCCCGCCGCACAGC.
Western blotting and immunofluorescence. Cell lysates (40 mg) were used for immunoblotting and resolved on 10% SDS-PAGE and transferred to PVDF membranes. Membranes were incubated in primary and secondary antibodies for 1 h each. Primary antibodies used include B-actin (Sigma, A2228) at 1:2,500, DNMT1 (BD Pharmingen, 612618) at 1:500, UHRF1 (Abcam, ab46187) at 1:100 and Involucrin (Sigma, I9018) at 1:250. Sheep anti-mouse or rabbit-horseradish peroxidase (HRP; Amersham Biosciences) secondary antibodies were used at 1:4,000. For immunofluorescence experiments, 7-mm-thick epidermal sections from adult human skin or xenografts were fixed in 4% paraformaldehyde for 15 min followed by blocking in PBS with 2.5% normal goat serum, 0.3% triton X100, and 2% bovine serum albumin for 30 min. Sections were incubated in primary antibodies for 1 h. In vivo epidermal progenitor cell tracking system. Marked epidermal cells were generated by transducing the cells with the HA tagged retroviral constructs. Cells were then transduced with retroviral constructs to knockdown DNMT1 or control. Transduced cells were selected for knockdown constructs using puromycin. These modified cell were mixed at a 50:50 ratio with non-marked cells and grafted onto immune deficient mice to regenerate human epidermis.
Quantitative reverse transcriptase-PCR analysis. Total RNA from cells was extracted using the RNeasy mini kit (Qiagen) and quantified by NanoDrop. Total RNA (1 mg) was reverse transcribed using the 1st Strand cDNA Synthesis Kit for RT-PCR from Roche. Quantitative PCR was performed using the Mx3000P (Stratagene) thermocycler. Samples were run in triplicate and normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Primer sequences for GAPDH, S100A8, IVL, and SPRR3 were the same as previously published 31 . Sequences for P15, P16, UHRF1, POU2F3, DNMT1, S100P, LCE3D, GADD45A, and GADD45B are as follows: P15 for, AAAGCCCGGAGCTAACGAC, P15 rev, CTCCTCGGCCAAGTCCAC; P16 for, CCCAACGCACCGAATAGT; P16 rev, GCAGCACCACCAGCGTGTC; UHRF1 for, GTGGGATGAGACGGAATTG; UHRF1 rev, CGGGTAGTCGTCGTATTTC; POU2F3 for, CAGACCACCA TCTCACGAT; POU2F3 rev, GGATGTTGGTCTCGATGC; DNMT1 for, CTGAGGCCTTCACGTTCA; DNMT1 rev, CTCGCTGGAGTGGACTTGT; S100P for, GATGGAGAAGGAGCTACC; S100P rev, CTCTGCCAGGAATCT GT; LCE3D for, GCTGCTTCCTGAACCAC; LCE3D rev, GGGAACTCATGC ATCAAG; GADD45A for, AGCAGAAGACCGAAAGGA; GADD45A rev, GCCACATCTCTGTCGTCGT; GADD45B for, TCAACATCGTGCGGGTGTC; GADD45B rev, CCCGGCTTTCTTCGCAGTA. The following primer sequences for muscle differentiation genes were used: TPM1 for, GCTGAGAAGTAC TCGCAG; TPM1 rev, ATCGTTGAGAGCGTGGT; MYH8 for, GTCAAGGT TGGCAATGAG; MYH8 rev, CAAACATGTGGTGGTTGAA; ACTA1 for, CCTGGAAAAGAGCTACGA; ACTA1 rev, GGCGATGATCTTGATCTTC. Gene expression profiling. Microarray analysis was performed on biological duplicate samples. Labelling of cDNA and hybridization to Affymetrix HG-U133 2.0 plus arrays were performed at Stanford's P.A.N. facility. For gene expression analysis, arrays were robust multi-array average normalized and differential expression was defined using the following filters: significance analysis of microarrays 3.0 (ref. 32 ) with a false discovery rate less than 5%, an average fold change $2 in any group, and an average raw expression intensity $100in any group. Hierarchical clustering and heat map generation were performed using GeneSpring GX software (Agilent). For future analyses, Affymetrix probe IDs were converted to unique Entrez IDs. P-values indicating the significance of the overlap between various gene sets were calculated using Fisher's exact test. Gene ontology term enrichment was performed using DAVID with the total set of genes on the appropriate microarray as the background (full genome for the MeDIP profiling), P-values represent a Bonferroni-corrected modified Fisher's exact test 33 . Apoptosis assays. Apoptotic assays in cultured cells were performed by using the Annexin V-FITC apoptosis detection kit (BD Pharmingen, 556547). Assays were performed according to the manufacturer's protocol using the FACSCalibur (Becton Dickinson) flow cytometer. Epidermal tissue was stained for apoptosis using the In situ Cell Death Detection kit (Roche, 12156792910) according to the manufacturer's protocol. Cell cycle analysis. Cell cycle profiles were determined by analysing propidium iodide-stained DNA using flow cytometry as previously described 34 .
Clonogenic assays. For clonogenic assays with primary human keratinocytes, 100 cells were plated onto mitomycin-C-treated (15 mg ml 21 ) 3T3 feeder cells in a 30 mm Petri dish. Colonies were fixed with cold methanol/acetone, stained using crystal violet (Fisher Scientific, S71262-1) and counted 2 weeks after plating. Methylated DNA immunoprecipitation (MeDIP) and DNA methylation profiling. Genomic DNA was isolated from cells using the DNeasy kit (Qiagen). The DNA was sonicated to produce fragments ranging between 300 and 1,000 bp and subject to immunoprecipitation using a monoclonal antibody against 5-methylcytidine (Eurogentec) according to published protocols 35, 36 . DNA enriched for 5-methylcytidine was subject to amplification using the Whole Genome Amplification Kit (Sigma) according to manufacturer's protocol. Amplified DNA was labelled and hybridized to NimbleGen's HG18 tiled promoter arrays which includes all known RefSeq genes, annotated splice variants, the mammalian gene collection and UCSC known genes. On average the promoters were tiled ,3,500 bp upstream and ,750 bp downstream of the gene. The median probe spacing is ,100 bp with probe length being 50-75 nucleotides. Labelling, hybridization and data analysis were all performed by NimbleGen using standard protocols. Significantly methylated peak regions were identified by NimbleScan software using default parameters for the onesided Kolmogorov-Smirnov (KS) test. Details of the software and peak calling algorithm are available on the NimbleGen website (http://www.nimblegen.com/ products/software/). NimbleScan was also used to map the called peaks to unique RefSeq IDs. To determine methylated regions specific to the undifferentiated state, we used Galaxy software 37 (http://www.g2.bx.psu.edu) to identify peaks that overlap between undifferentiated (2Ca 21 ) and differentiated (1Ca 21 ) conditions. This overlapping set was then subtracted from the total set of peaks identified in the 2Ca 21 sample. To identify genes that may be inhibited by methylation in 2Ca 21 conditions, we overlapped genes containing 2Ca 21 -specific methylation with those determined to be transcriptionally induced during differentiation. MeDIP data visualization. Genomic coordinates in which significantly methylated peak regions in undifferentiated (2Ca 21 ) and differentiated (1Ca 21 ) conditions were submitted to the UCSC Genome Browser as custom tracks and visualized relative to annotated tracks of CpG Islands and RefSeq genes. The resulting visualizations of selected genes were adapted to include regions tiled on the Nimblegen Promoter Tiling Array within an average viewing window of 23,500bp to 11,000 bp relative to the gene transcription start site. Quantitative PCR on MeDIP samples. Real time PCR was carried out using 50 ng of input as well as amplified MeDIP samples. For QPCR detection, the SYBR Green PCR master mix (Invitrogen) was used with the Mx3000P (Stratagene) machine. To determine the relative enrichment of target sequences, the ratio of the signals in the MeDIP samples were compared to input DNA. The resulting values were standardized against the input, which was given a value of 1. The primers used for the promoter regions are as follows: mS100P for, CCAGCCAAGGAACGGACC; mS100P rev, CAGCCCTGGATTGCATTC; mKCNQ1 for, GGCCTGGATTTACTCAG; mKCNQ1 rev, CCCTTCCTCTG CCTATCT; mLCE3D FOR, CTGAAGCTAGGTTTGAAC; mLCE3D REV, GGGTTTCAGCACTGAATA; mPOU2f3 for, CTGGGGCAGAGGCGAGG; and mPOU2f3 rev, AACCCGCTATCCACACCG. Bisulphite sequencing. DNA was isolated from cells using Qiagen's DNeasy kit. DNA from each sample (1 mg) was treated with bisulphite using the EpiTect Bisulfite kit (Qiagen). Promoter region 2507 to 2139 was amplified using the following primers: S100P for, GAAGTTGGGTTTTTGAAGGATATAG; S100P rev, CCCAAAATATAAACTACCTCCAAAC. CpG island analysis. To determine the presence of CpG islands upstream of 232 genes exhibiting both 2Ca 21 -specific methylation and induction during differentiation, we used Galaxy to (1) convert the Gene Symbols into corresponding RefSeq IDs, (2) determine the transcription start site (TSS) for each RefSeq ID, and (3) find CpG island annotations 38 from the UCSC Table Browser 39 within 2 kb upstream of the TSS. Finally, we also used Galaxy to determine if any of the 256 unique MeDIP peaks identified in basal growth conditions (corresponding to the 232 genes) overlapped with the annotated chromosomal positions of any of the 28,226 annotated CpG islands in the genome. Note that 19 genes in Supplementary Table 7 have CpG islands that do not fall 2 kb upstream of TSS, but do overlap with identified methylation peaks. For each of these analyses, we used the March 2006 human reference sequence (NCBI Build 36.1).
